Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapeutics 2000].

A J Scheen1

  • 1Service de Diabétologie, Université de Liège.

Revue Medicale De Liege
|December 6, 2000
PubMed
Summary
This summary is machine-generated.

This review highlights key new drugs for internal medicine in Belgium, focusing on their unique benefits and proper clinical application. It aids healthcare professionals in understanding recent therapeutic advancements.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Drug Development

Context:

  • Overview of recent drug registrations and launches in Belgium.
  • Focus on internal medicine disciplines.
  • Analysis of novel therapeutic agents.

Purpose:

  • To describe the most important new drugs in Belgian internal medicine.
  • To emphasize the originality and clinical utility of these molecules.
  • To guide appropriate use in clinical practice.

Summary:

  • Presents a curated selection of significant new pharmaceutical products.
  • Details the unique properties and mechanisms of action.
  • Provides guidance on integrating these drugs into patient care.

Impact:

  • Facilitates informed decision-making for clinicians.
  • Enhances understanding of recent pharmaceutical innovations.
  • Supports the optimization of internal medicine treatments in Belgium.